Skip to main content

Table 2 Concentrations of IL-17 and CD40L in CSF and serum samples analysed

From: Th17-skewed immune response and cluster of differentiation 40 ligand expression in canine steroid-responsive meningitis-arteritis, a large animal model for neutrophilic meningitis

Groups

 

IL-17 (pg/mL)

CD40L (ng/mL)

CSF

Serum

CSF

Serum

SRMA A

Median

901.77

45.95

0.51

1.37

Range

(70.73–2967.14)

(12.18–251.53)

(0.16–1.95)

(0.25–3.10)

Percentage of zeros

0%

50%

50%

–

SRMA R

Median

533.01

43.30

0.22

1.37

Range

(97.52–1771.87)

(12.52–126.74)

(0.17–0.91)

(0.76–3.06)

Percentage of zeros

0%

16.67%

33.33%

–

SRMA T

Median

29.67

21.04

0

1.29

Range

(12.47–78.86)

(8.10–32.92)

(0–0)

(0.29–6.39)

Percentage of zeros

38.46%

59.26%

100%

–

Healthy

Median

30.90

32.34

0.17

1.70

Range

(15.45–172.17)

(9.40–87.46)

(0.17–0.17)

(0.38–5.75)

Percentage of zeros

8.33%

14.29%

92.86%

–

Miscellaneous

Median

53.54

10.98

0.63

1.08

Range

(13.64–221.82)

(8.65–13.30)

(0.63–0.63)

(0.48–5.80)

Percentage of zeros

30%

69.23%

72.73%

–

  1. Median and range (minimum-maximum) of values above the detection limits and percentage of zeros for each group
  2. IL-17 interleukin-17, CD40L cluster of differentiation 40 ligand, CSF cerebrospinal fluid, SRMA A steroid-responsive meningitis-arteritis in acute stage, SRMA R recurrence of SRMA, SRMA T SRMA patients under treatment